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patients’ symptom states and adjust their 
treatment accordingly. However, clinicians 
are not aware if a patient experiences 
deteriorated symptoms between visits. 
Because of this gap of knowledge in 
outpatient management between visits, 
clinicians are more likely to miss the 
optimal time to intervene to treat patients 
who are increasingly symptomatic and 
experiencing increased risk of relapse. The 
high cost of hospital visits and face-to-face 
assessments further prohibits patients from 
more frequent visits with their clinicians to 
adjust treatment or provide intervention.
In order to address these shortcomings, 
we developed the CrossCheck symptom 
prediction system to monitor patients’ 
trajectory of psychiatric symptoms. The sys- 
tem predicts patients’ weekly 7-item Brief 
Psychiatric Rating Scale (BPRS) total scores 
using passive sensing and self-reported 
ecological momentary assessment (EMA) 
responses from smartphones. Weekly 
predictions track participants’ overall 
psychiatric symptoms and level of risk for 
relapse. The 7-item BPRS is a subset of the 
original 24-item BPRS, which measures 
Schizophrenia is a severe chronic psychiatric 
disorder associated with high individual  
and societal costs. Psychosis is not 
considered as a fixed state. Rather, the 
majority of people with schizophrenia 
fluctuate between full or partial remission 
and episodes of symptomatic relapse.  
Psychotic symptoms may change over 
months, weeks, or even days, and can be 
affected by both external conditions and 
internal states [2]. In the case of relapse, 
patients may find themselves suffering severe 
hardship if not helped, such as homelessness, 
incarceration, and victimization. Patients 
are often hospitalized as a consequence of 
schizophrenia relapse. 
Clinicians need to track schizophrenia 
patients’ symptom states to identify risks 
and adjust treatment as necessary. At the 
CrossCheck study [1,2,3] partner hospital, 
Zucker Hillside Hospital, in New York City, 
schizophrenia outpatients regularly schedule 
clinical visits with their clinicians. The time 
between visits varies from once a week to 
once a month, depending on the patients’ 
symptom severity and risk. Clinicians use a 
battery of mental health tests to evaluate the 
psychiatric symptoms associated with 
schizophrenia. The clinical team at our study  
partner hospital determines the 7 BPRS 
items (grandiosity, suspiciousness, hallucina- 
tions, unusual thought content, conceptual 
disorganization, blunted affect, and manner- 
isms and posturing) to be the strongest 
predictors of deterioration in symptoms. 
The 7-item BPRS is administered by a trained 
clinician at our study partner hospital. 
The scored 7-item BPRS survey serves as a 
clinical indicator of treatment for patients 
who have moderate to severe disease. 
In this paper, we present 7-item BPRS 
prediction results from an ongoing random- 
ized control trial (RCT), in which passive 
sensor data, self-reports and clinically 
administered 7-item BPRS reports are  
collected from 36 outpatients with schizo- 
phrenia, who have been recently discharged 
from hospital over a period ranging from 2 
to 12 months. We show that our system can 
predict 7-item BPRS using a combination of 
passive sensing data and self-reported EMA. 
Importantly, we also show that we can 
predict 7-item BPRS scores based purely on 
passive sensing data from mobile phones. 
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Continuously monitoring schizophrenia patients’ psychiatric symptoms is crucial for in-time intervention and treatment adjustment. The Brief Psychiatric Rating Scale (BPRS) is a survey administered by clinicians to evaluate symptom severity in schizophrenia. The CrossCheck symptom prediction system is capable of 
tracking schizophrenia symptoms as measured by BPRS using passive sensing from mobile phones. We present 
results from a randomized control trial, where passive sensing data, self-reports, and clinician administered 
7-item BPRS surveys are collected from 36 outpatients with schizophrenia. We show that our system can 
predict a symptom scale score based on a 7-item BPRS within ±1.45 error on average. Finally, we discuss how 
well our predictive system reflects symptoms experienced by patients by reviewing a case study. 
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CROSSCHECK STUDY
Th e CrossCheck study is an on-
going randomized controlled trial 
[6] conducted in collaboration with 
a large psychiatric hospital, Zucker 
Hillside Hospital, in New York City 
[3]. Th e study aims to recruit 150 
participants for 12 months using 
rolling enrollment. Th e participants 
are randomized into one of two 
study arms: smartphone (n=75) 
or treatment-as-usual (n=75) [3]. 
Figure 1 shows an overview of the 
CrossCheck symptom prediction 
system. Th is study is approved by the 
Committee for Protection of Human 
Subjects at Dartmouth College and 
Institutional Review Board at Northwell 
Health System. 
We use the study hospital’s electronic 
medical record to identify potential 
study candidates. A candidate is a patient 
who is 18 or older, meets DSM-IV or 
DSM-V1 criteria for schizophrenia, 
schizoaff ective disorder or psychosis, and 
has had psychiatric hospitalization, daytime 
psychiatric hospitalization, outpatient crisis 
management, or short-term psychiatric 
hospital emergency room visits within 
12 months before study entry. Th e study 
candidates are randomly assigned to either 
the smartphone arm or treatment-as-usual 
arm. Participants in the smartphone arm 
are given a Samsung Galaxy S5 Android 
phone equipped with the CrossCheck app. 
Participants’ personal phone numbers are 
migrated over to the new phone and they 
are provided with an unlimited data plan 
for data uploading. 
Th e CrossCheck app [3] is built based 
on our prior sensing work [4,7,11]. Th e app 
continuously infers and records participants’ 
physical activities (e.g., stationary, in a 
vehicle, walking, running, cycling), sleep 
(duration, bedtime, and rise time), and 
sociability (i.e., the number of independent 
conservations a participant is around and 
their duration). Th e app also collects audio 
amplitude, accelerometer readings, light 
sensor readings, location coordinates, 
application usages, and call logs. Th e app 
uses a built-in MobileEMA component [11] 
to administer self-reported EMAs [5]. To 
protect participants’ privacy, the app does 
not collect phone numbers, content of text 
messages or any conversation content. We 
remotely erase the CrossCheck data on 
the phone and reset it if the phone is lost. 
Th e app uploads the data to the secured 
CrossCheck data analytics service in the 
cloud when participants are charging their 
phones, with Wi-Fi or cellular data services. 
See [3] for more detailed discussion of the 
implementation of the phone application 
and system.
Participants schedule monthly visits 
with their clinicians. During their visits, 
clinicians administer the 7-item BPRS. 
Th e 7-item BPRS score ranges from 7 to 
49. Higher scores are associated with more 
severe symptoms. Th e clinician-rated 7-item 
BPRS scores are used as the ground truth for 
training the 7-item BPRS prediction model.
Th e CrossCheck system predicts 
participants’ BPRS scores every week. 
Th e prediction system sends out a 7-item 
BPRS prediction report every week to 
research staff  by email. Th e prediction 
report shows the participant’s predicted 
7-item BPRS scores for the last 3 weeks. 
Our research staff  use the predicted 7-item 
BPRS scores over the preceding 2-week 
period to identify any patients who may 
be potentially at risk. A patient at risk is 
one whose predicted 7-item BPRS score is 
above 12 or experiences an increase of 10% 
or more since their last predicted 7-item 
BPRS score. Th e research and clinical teams 
determined the rising risk threshold criteria 
(i.e., the score cut off  and percent change) 
by studying the historical BPRS scores 
from patients who experienced relapse; 
that is, we analyzed scores in time periods 
prior to relapse to determine the cut-off  
and, in addition, because some patients’ 
data prior to relapse showed a lower cutoff  
but large increasing percent changes, we 
also determined the additional criteria of 
the 10% change or greater between two 
predictions as a red fl ag.
CROSSCHECK DATASET
Th e CrossCheck dataset comprises the 
participants’ monthly 7-item BPRS scores 
rated by their clinicians, behavioral features 
extracted from passive sensing, and 
symptom features extracted from self-report 
EMAs. We use 30 days of sensing and self-
report EMA data to predict a 7-item BPRS 
score. Th e 30-day time frame is called the 
7-item BPRS prediction time frame. Th e 
30-day time frame matches the interval 
of clinician rated 7-item BPRS, which is 
30 days on average. Th e passive sensing 
features summarize the level of behaviors 
(e.g., the average conversation duration 
per day in the 30-day time frame) and 
behavior changes (e.g., increase or decrease 
in conversation duration and the dynamics 
– for example direction and steepness – of 
change) in the 7-item BPRS prediction 
time frame. To compute a feature for the 
prediction time frame, we fi rst compute 
the daily feature time series from the raw 
1 Diagnostic and Statistical Manual of Mental 
Disorders (DSM–5): https://www.psychiatry.org/
psychiatrists/practice/dsm
FIGURE 1. System overview of the CrossCheck symptom prediction system.
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sensing data. We then compute the 30-day 
features from the daily feature time series. 
In what follows, we discuss the construction 
of the dataset in detail.
The CrossCheck app collects a wide 
range of behavioral passive sensing data 
from the phone. This data captures physical 
activity, sociability (based on speech and 
conversational data), mobility, sleep, phone 
usage, and characteristics of the ambient 
environment in which participants dwell. 
We compute daily features from the passive 
sensing data, for example, conversation 
duration during a day. Patients periodically 
respond to a set of short questions related to 
their symptoms and functioning using their 
phones. The CrossCheck app administers a 
10-item EMA [3] every Monday, Tuesday 
and Friday. We use each item’s score as a 
self-report feature to capture symptoms and 
affects. We also calculate the EMA negative 
score, positive score, and sum score from 
the responses [3].
We compute mean and slope for each of 
the passive sensing features and self-report 
EMA items during the 30-day 7-item BPRS 
prediction time frame. In order to ensure 
that we have enough data to compute the 
mean and slope for each passive data, we 
include only the data in our analysis that 
satisfies the following criteria. We define 
a “good day” as a day with more than 19 
hours of the sensing data. In order to avoid 
missing data and skewing the time series 
features in the prediction time frame, we 
need to control the data completeness in the 
30-day time frame. We include time frames 
with more than 20 good days of the sensing 
data. We use 116 7-item BPRS records and 
corresponding features from 36 participants 
for evaluating the 7-item BPRS prediction 
performance. 
PREDICTION MODEL  
AND RESULTS
We use Gradient Boosted Regression Trees 
(GBRT) [9] to predict the 7-item BPRS 
scores. GBRT is an ensemble method that 
trains and combines several weak regression 
trees to make accurate predictions. In order 
to understand the prediction accuracy of 
the three different feature setups, we train 
three models with (i) using both the passive 
sensing features and the EMA features; 
(ii) using just the passive sensing features; 
and (iii) using just the EMA features. We 
evaluate the prediction accuracy with leave-
one-record-out cross validation and leave-
one-subject-out cross validation. The leave-
one-record-out cross validation leaves one 
7-item BPRS example out from the dataset 
as the testing example and uses the rest of 
the examples for training the model. The 
results from the leave-one-record-out cross 
validation show the prediction accuracy of 
predicting an existing participant’s 7-item 
BPRS score. The participant’s previous 
clinician-rated 7-item BPRS scores are 
available to the system to improve the 
prediction accuracy by incorporating the 
data in the training examples. The leave-
one-subject-out cross validation trains the 
model with data from subjects other than 
the testing subject and tests on the testing 
subject’s data. The results from the leave-
one-subject-out cross validation shows the 
prediction accuracy of predicting a new 
participant who just joined the study when 
their clinician-rated 7-item BPRS scores are 
not available to the system.
We use mean absolute error (MAE), 
the Pearson’s r, and generalized estimating 
equations (GEE) [8] to evaluate the 
prediction performance. MAE describes 
the bias of the predictions. The Pearson 
correlation treats the predicted BPRS scores 
as independent variables. The Pearson’s r 
describes how well the predictions capture 
the outcome’s variance. GEE focuses on 
estimating the average response over the 
population [8]. It is a more robust method 
to evaluate correlations between repeated 
measures. The GEE coefficient shows the 
direction of the correlation and the p-value 
indicates the statistical significance of the 
coefficient.
Table 1 shows the mean absolute error, 
the Pearson’s r, and GEE coefficient for all 
models predicting the BPRS score. The 
leave-one-record-out cross validation with 
both passive sensing and EMA features 
achieves the best result with MAE = 1.45, 
meaning we can predict the 7-item BPRS 
score with on average ±1.45 error. The 
predicted 7-item BPRS scores strongly 
correlate with the 7-item BPRS ground 
truth with r = 0.70, p < 0.0001. Using only 
passive sensing or the EMA feature obtains 
slightly poorer MAE. The result shows that 
our existing system can accurately predict 
patients’ 7-item BPRS scores. The result 
gives us confidence to track symptoms 
every week. The prediction performance for 
leave-one-subject-out cross validation using 
only passive sensing or EMA features is 
MAE = 1.80, r = 0.48, p < 0.0001 and MAE 
= 1.90, r = 0.50, p < 0.0001 (4.5% of the 
scale), respectively. When comparing, using 
both passive sensing and EMA features, this 
results in a 0.1 and 0.2 increase in absolute 
errors, respectively. Again, passive sensing 
features outperform EMA features in terms 
of MAE. In both cross validations, we see 
that combining the passive sensing and 
EMA features performs better than just 
using passive sensing features, which in turn 
outperforms EMA features.
Figure 2 shows the average within-
individual prediction error of the two 
models with the different feature setups 
and cross-validation methods. The order 
of the patients shown in the plots is 
determined by their average clinician-rated 
BPRS scores. We observe that our models 
archive lower prediction errors on patients 
with lower clinician-rated BPRS scores 
but higher errors on patients with higher 
clinician-rated BPRS scores. Most of the 
clinician-rated BPRS scores are between 7 
and 12. Therefore, the dataset is unbalanced 
   passive sensing + EMA passive sensing EMA
  MAE 1.45 1.59 1.62
leave-one-record-out Pearson’s r 0.70* 0.63 0.62*
 GEE coeff 1.05* 1.11 0.81*
 MAE 1.70 1.80 1.90
leave-one-subject-out Pearson’s r 0.61* 0.48 0.50*
 GEE coeff 0.99* 0.93 0.81*
 * p < 0.0001
TABLE 1. Prediction Performance
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and skews to lower BPRS scores (≤ 12). The 
GBRT models are undertrained for higher 
BPRS scores (> 12). As a result, the models 
underestimate high-BPRS-score patients’ 
scores (i.e., patients with average BPRS 
> 12). The prediction models need more 
high-BPRS-score patients’ data to improve 
the prediction performance.
Clinicians may use the predicted 
BPRS scores to assess patients’ symptoms. 
Our research team sets the score cutoff 
for symptom deterioration to 12. For 
patients with a BPRS score less than 12, a 
positive error may lead to a false positive 
of symptom deterioration. For example, if 
a patient is rated as 11 but the predicted 
BPRS score is 12.5, the patient would be 
falsely labeled with symptom deterioration. 
Conversely, for patients with BPRS scores 
higher or equal to 12, a negative error 
may lead to a false negative of symptom 
deterioration. However, if a patient is rated 
a higher score, it allows a larger margin 
of error. For example, if a patient would 
be rated as 20, the same as patient 36 as 
shown in Figure 2(a), a prediction error of 
-6 (i.e., predicted BPRS score is 14) is still 
a true positive. Since our models tend to 
underestimate high-BPRS-score patients’ 
BPRS score, clinicians could use a lower 
symptom deterioration cutoff amongst the 
high-BPRS-score patients to reduce the 
false negative rate.
PATIENT CASE STUDIES
The CrossCheck prediction model is 
retrained each week if new clinician-rated 
7-BPRS scores are available. Each week our 
research staff reviews the weekly prediction 
scores of all patients using the smartphone. 
Once we identify that a patient might be 
at risk, our research staff outreach and 
contact the participant and the clinical 
team at the hospital. In what follows, we 
provide insights into the life of one patient 
at the time our system indicates increasing 
symptoms. We show through anecdotal 
information from research staff and the 
clinical team reaching out to patients when 
the prediction system indicates rising risk.
The patient is a 55-year-old African 
American male diagnosed with 
schizophrenia, paranoid type. He was 
clinically flagged on Aug. 22, 2016, based 
on an elevated predicted 7-item BPRS 
score of 12.86. When our research staff at 
the hospital contacted the patient on 
Aug. 24, 2016, he endorsed symptom 
decompensation over the past three 
months with increasing intensity over 
the past three weeks. He discussed 
negative thoughts he had had about 
his deceased mother who had passed 
away five years earlier. The patient also 
said he believed these thoughts were 
present to make him feel “emotionally 
sick.” The on-site researcher and 
patient discussed coping mechanisms. 
Once the researcher determined that 
the patient was not in any imminent 
danger, the researcher encouraged him 
to share all these symptoms with his 
treatment team and then brought the 
call to an end. The researcher contacted 
the clinical team to inform them of the 
symptoms reported by the patient. The 
patient’s psychiatrist reviewed the new 
information and told the researcher that 
the patient had been experiencing difficulty 
scheduling his next outpatient medication 
management appointment. The psychiatrist 
immediately reached out to the patient’s case 
manager to coordinate an in-person visit, 
which occurred less than a week after the 
initial research outreach. The psychiatrist 
adjusted his medication accordingly during 
the clinical visit. This case shows that the 
predictive system, outreach and clinical 
assessment all concur strongly.
CONCLUDING REMARKS
The CrossCheck system discussed in 
this paper shows promise in using 
mobile phones and passive sensing to 
predict symptoms of schizophrenia for 
people living out in the community. The 
system and models show extremely good 
performance using passive sensing and self-
reports as well as when just using passive 
sensing. A system based purely on passive 
sensing opens the way for continuous 
assessment of symptoms and risk as people 
go about their everyday lives.
We also recognize the limitations 
of our work. We only had 116 BPRS 
clinician-scored surveys to train our 
model. Outpatients do not experience 
severe symptoms often and thus report 
lower 7-item BPRS scores. Therefore, 
the dataset is unbalanced and skews 
to lower BPRS scores. The unbalanced 
dataset causes our prediction models to 
underestimate the BPRS scores of patients 
with higher clinician-rated BPRS scores. 
However, we showed that clinicians 
may adjust the score cutoff for symptom 
deterioration and leverage the changes 
in predicted BPRS scores to reduce the 
false negatives. To further advance BPRS 
prediction, we need to collect more data, 
especially from patients with more severe 
symptoms. We would need to apply re-
sampling techniques, such as SMOTE 
[10], to balance the dataset. Another 
possible limitation is that all patients live 
in a large, dense city and the models may 
not generalize to other locations, such as 
patients living in rural communities. 
The CrossCheck symptom prediction 
system accurately captured the changing 
conditions of these patients as reported by 
the research and clinical teams that reached 
out to them or interacted with them during 
[HIGHLIGHTS]
FIGURE 2. The average within-individual 
prediction error of the six models. The patients 
are ordered by their average rated BPRS scores. 
The vertical dashed line separate patients with 
average BPRS score ≤ 12 and patients with BPRS 
score > 12. The horizontal lines label the region 
with prediction error more than -2 and less than 
2. Patients with higher-rated BPRS scores get 
worse predictions. This is because the dataset is 
skewed to patients with lower BPRS scores.
(a) Passive sensing + EMA leave-one-record-out.
(b) Passive sensing + EMA leave-one-subject-out.
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